ArticleJTO clinical and research reports2021

Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy.

Sally C M Lau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.